Biocompatibility and Antifungal Effects of Chitosan Nanoparticles Loaded With Nystatin and Carvacrol Against Candida albicans
Journal of Oral Pathology & Medicine · 2026
DOI: 10.1111/jop.70174 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Oral Pathology & Medicine, 2026. Verfasst von Samaneh Fattahi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dental Biomaterials, Faculty of Dentistry, Tabriz University of Medical Sciences, Tabriz, Iran. Hauptthemen laut MEDLINE: Nystatin, Chitosan, Antifungal Agents, Candida albicans. Die Arbeit nennt 58 Literaturangaben. Gefördert von: Tabriz University of Medical Sciences.
Abstract (Originalsprache)
Background
Nanocarrier‐based drug delivery systems enable the co‐administration of antifungal agents, enhancing pharmacological efficacy and creating synergistic effects. This study aimed to evaluate the biocompatibility and antifungal properties of chitosan nanoparticles co‐loaded with nystatin and carvacrol against Candida albicans .
Methods
Chitosan nanoparticles were synthesized and loaded with nystatin and carvacrol. Their antifungal activity was evaluated by determining the minimum inhibitory concentration (MIC) and checkerboard synergy assays, while antibiofilm activity was measured using a microtiter plate crystal violet assay. Biocompatibility was assessed through hemolysis testing of human red blood cells (HRBCs) and MTT cytotoxicity assays on human foreskin fibroblasts (HFF).
Results
The nanoparticles exhibited an average hydrodynamic diameter of 70 ± 1.2 nm with favorable polydispersity (0.21 ± 0.03). The MIC of co‐loaded nanoparticles was significantly lower than that of single‐drug loaded nanoparticles, and checkerboard assays confirmed strong synergy (FICI 0.16–0.5). Sub‐MIC concentrations markedly reduced biofilm formation. At 1000 μg/mL, drug‐loaded nanoparticles induced < 5% hemolysis, compared with 15.7% ± 2.7% for blank chitosan nanoparticles. HFF cell viability exceeded 90% across concentrations up to 1000 μg/mL at 24–72 h.
Conclusion
Co‐loading nystatin and carvacrol into chitosan nanoparticles yielded a synergistic antifungal and antibiofilm effect against C. albicans , coupled with excellent hemocompatibility and minimal cytotoxicity, highlighting its potential as a topical therapeutic for oral candidiasis particularly where resistance to azoles is rising. Further in vivo studies are warranted.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Dental Biomaterials, Faculty of Dentistry, Tabriz University of Medical Sciences, Tabriz, Iran.
- Dental and Periodontal Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
- Department of Anesthesiology and Intensive Care Medicine, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
- Infectious and Tropical Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
ORCID-Profile: Solmaz Maleki Dizaj, Mina Yekani, Mohammad Yousef Memar
Förderung
- Tabriz University of Medical Sciences
Zitieren
APA
Fattahi, S., Maleki Dizaj, S., Yekani, M., Bahramian, M., Bahramian, A., & Memar, M. Y. (2026). Biocompatibility and Antifungal Effects of Chitosan Nanoparticles Loaded With Nystatin and Carvacrol Against Candida albicans. Journal of Oral Pathology & Medicine. https://doi.org/10.1111/jop.70174
Vancouver
Fattahi S, Maleki Dizaj S, Yekani M, Bahramian M, Bahramian A, Memar MY. Biocompatibility and Antifungal Effects of Chitosan Nanoparticles Loaded With Nystatin and Carvacrol Against Candida albicans. Journal of Oral Pathology & Medicine. 2026. doi:10.1111/jop.70174
BibTeX
@article{Fattahi2026,
author = {Fattahi, Samaneh and Maleki Dizaj, Solmaz and Yekani, Mina and Bahramian, Maria and Bahramian, Ayla and Memar, Mohammad Yousef},
title = {Biocompatibility and Antifungal Effects of Chitosan Nanoparticles Loaded With Nystatin and Carvacrol Against Candida albicans},
journal = {Journal of Oral Pathology & Medicine},
year = {2026},
doi = {10.1111/jop.70174}
}
EUVIMED